Literature DB >> 11092261

Severe exacerbation of hepatitis after short-term corticosteroid therapy in a patients with "latent" chronic hepatitis B.

G Shiota1, K Harada, K Oyama, A Udagawa, T Nomi, K Tanaka, A Tsutsumi, N Noguchi, Y Kishimoto, Y Horie, T Suou, H Kawasaki.   

Abstract

We present a case of severe exacerbation of hepatitis after short-term corticosteroid therapy for chronic inflammatory demyelinating polyneuropathy (CIPD) with "latent" chronic hepatitis B showing no HBV-related antigens and antibodies. After corticosteroid pulse therapy for CIPD, the patient had severe exacerbation of hepatitis twice. Although she did not show any hepatitis B virus (HBV)-related antigens or antibodies, sequences of HBV were detected in serum and liver by a nested polymerase chain reaction. A sequence analysis of HBV at the second exacerbation showed that the G-to-A point mutation at nucleotide 1896 that converted codon 28 from tryptophan (TGG) to a stop codon (TAG) in the precore region resulted in amino acid change, which has been frequently observed in fulminant hepatitis and severe hepatitis in Japan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092261     DOI: 10.1034/j.1600-0676.2000.020005415.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  7 in total

Review 1.  An overview of SARS-COV-2-related hepatic injury.

Authors:  Abdullah Tarik Aslan; Hatice Yasemin Balaban
Journal:  Hepatol Forum       Date:  2021-09-15

2.  Outcome of various treatments for posttransplant hepatitis B virus recurrence.

Authors:  Nam-Joon Yi; Kwang-Woong Lee; Sun-Young Kong; Kyoung-Un Park; Kyoung-Bun Lee; Geun Hong; Sung-Sik Han; Sang-Jae Park; Kyung-Suk Suh
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

3.  Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo.

Authors:  Zhong-Yang Shen; Wei-Ping Zheng; Yong-Lin Deng; Hong-Li Song
Journal:  Viral Immunol       Date:  2012-09-04       Impact factor: 2.257

4.  Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B.

Authors:  YuFeng Lou; ManYi Wang; WeiLin Mao
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

5.  Modulation of Covid-19 cytokine storm by tocilizumab.

Authors:  Alberto Boretti; Bimal Banik
Journal:  J Med Virol       Date:  2021-10-23       Impact factor: 20.693

Review 6.  Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.

Authors:  Antonio Saviano; Florian Wrensch; Marc G Ghany; Thomas F Baumert
Journal:  Hepatology       Date:  2021-06-18       Impact factor: 17.298

7.  Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature.

Authors:  Seyed Mohsen Dehghani; Seyed Ali Reza Taghavi; Bita Geramizadeh; Saman Nikeghbalian; Nima Derakhshan; Abdorrasoul Malekpour; Seyed Ali Malek-Hosseini
Journal:  Hepat Mon       Date:  2013-01-01       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.